Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R. Chappidi, Trinity J. Bivalacqua, Danny Lascano et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 130
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesNilay Gandhi, Trinity J. Bivalacqua, Alexander S. Baras et al.|Urologic Oncology Seminars and Original Investigations|2015Cited by 39
Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical CystectomyHeather J. Chalfin, Trinity J. Bivalacqua, Steven M. Frank et al.|Annals of Surgical Oncology|2016Cited by 37